Genesystem Co., Ltd. (KOSDAQ:363250)

Market Cap	73.56B
Revenue (ttm)	1.57B
Net Income (ttm)	-11.27B
Shares Out	7.03M
EPS (ttm)	-1,623.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,882
Average Volume	49,378
Open	10,600
Previous Close	10,350
Day's Range	10,190 - 10,750
52-Week Range	5,600 - 12,800
Beta	0.60
RSI	54.10
Earnings Date	n/a

About Genesystem

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nuc...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 363250